Reproductive Medicine
ReproNovo ApS focuses on clinical research in assisted reproduction, with particular attention to women undergoing in vitro fertilisation and intracytoplasmic sperm injection. The funded studies are centred on reproductive tract function and treatment-related outcomes relevant to fertility care.
- IVF and ICSI patient populations
- Uterine contractility
- Reproductive pharmacology
Clinical activity in this area reflects interest in therapies intended to support reproductive procedures and improve understanding of uterine response in fertility settings.
Pharmacokinetics and Drug Safety
The sponsor also supports research on the pharmacokinetics and safety of nolasiban, with attention to how the compound behaves in the body and its tolerability profile in human subjects.
- Pharmacokinetic profiling
- Safety evaluation
- Healthy volunteer studies
This area links early clinical development with reproductive indications and supports the assessment of treatment suitability in fertility-related care.
Pharmacodynamics and Uterine Function
Another key area of interest is the pharmacodynamics of nolasiban, particularly its effect on uterine motility and related physiological responses. The research addresses how different treatment regimens influence reproductive tract activity.
- Uterine motility
- Treatment response in fertility medicine
- Reproductive system physiology
These studies are aligned with therapeutic development in women’s health and reproductive care, where modulation of uterine activity is clinically relevant.
